BioNJ’s C-Suite Summit, set for October 25 in Bridgewater, brings together leaders and their teams from companies at all points along the development continuum — whether early or late-stage, public or private, revenue or pre-revenue — to share insights and ideas. The sessions will focus on how biopharma can leverage this pivotal juncture and pave the way for the next generation of patient life-changing therapies.
Read more and register here.